Search alternatives:
nn decrease » a decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
c decrease » c decreased (Expand Search), a decrease (Expand Search), rc decreased (Expand Search)
n decrease » a decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
_ decrease » _ decreased (Expand Search)
30 c » 3 c (Expand Search), 37 c (Expand Search), 30 _ (Expand Search)
nn decrease » a decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
c decrease » c decreased (Expand Search), a decrease (Expand Search), rc decreased (Expand Search)
n decrease » a decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
_ decrease » _ decreased (Expand Search)
30 c » 3 c (Expand Search), 37 c (Expand Search), 30 _ (Expand Search)
-
1
-
2
-
3
-
4
Decreased oscillatory flow decreases <i>klf2a</i> expression.
Published 2009“…(D) Embryos in which RFF was decreased by lidocaine treatment from 31 to 55 hpf have endocardial tissue thickening (asterisk) but no valve leaflets are apparent (50%, <i>n</i> = 36). …”
-
5
-
6
Transaldolase deficiency alters mitochondrial morphology and decreases <i>in vivo</i> mitochondrial respiration.
Published 2017“…RNAi treatments include <i>EV(RNAi)</i>, <i>tald-1(RNAi)</i> [50:50 with <i>EV(RNAi)</i>], <i>drp-1(RNAi)</i> [50:50 with <i>EV(RNAi)</i>], and <i>tald-1(RNAi)</i> [50:50 with <i>drp-1(RNAi)</i>]. …”
-
7
-
8
-
9
-
10
-
11
The GluN2B-C456Y mutation decreases recombinant NMDAR currents and alters receptor properties.
Published 2020“…<p>(A) The GluN2B-C456Y mutation strongly decreases diheteromeric GluN1/GluN2B NMDAR currents in <i>Xenopus</i> oocytes. …”
-
12
-
13
-
14
At lower concentrations, METH decreases LTP.
Published 2010“…At 0.1 µM METH, LTP was 1.58±.08 [<i>n</i> = 13(5)] (Fig. 1B); at 1 µM METH, LTP was 1.50±.07 [<i>n</i> = 13(7)] (Fig. 1C); at 10 µM METH, LTP was 1.58±.07 [<i>n</i> = 14(8)] (Fig. 1D); at 30 µM METH, LTP was 1.37±.06 [<i>n</i> = 15(4)] (Fig. 1E); and at 60 µM METH, LTP was 1.32±.24 [<i>n</i> = 4(2)] (Fig. 1E). …”
-
15
-
16
MiR-17 mimics decreased the viability of glioma C6 cells.
Published 2018“…<p>MTT assay was utilized to detect the cell viability of glioma C6 cells. MiR-17 mimics (50 nM) decreased the viability of glioma C6 cells dramatically compared to Lipofectamine control group at 24 and 48 h. ** indicates <i>p</i> < 0.01, and *** shows <i>p</i> < 0.001 when compared to Lipofectamine control group. …”
-
17
MiR-17 mimics decreased the migration of glioma C6 cells.
Published 2018“…<p>Cell wound scratch assay was utilized to examine the migration index of glioma C6 cells. MiR-17 mimics (50 nM) decreased the migration of glioma C6 markedly compared to Lipofectamine and negative control groups at 48 h. *** shows that <i>p</i> < 0.001 as compared to Lipofectamine control group. ## indicates that <i>p</i> < 0.01 and ### demonstrates that <i>p</i> < 0.001 as compared to NC control group. …”
-
18
-
19
-
20